Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Geoff Jamieson, Managing Director of Orcoda Limited (ASX: ODA), discusses the partnership with ShareRing Australia Pty Ltd.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Geoff Jamieson is Mng Dir/CEO at Orcoda Ltd.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Lost Cities Project: Uncovering Ecuador's Promising Exploration Potential
00:10:00
Apella’s James Femia explains the importance of early college planning during a child's Freshman or Sophomore year of high school for an effective financial strategy.|Patrick A. Sweeny is a founding partner of Apella Capital.
00:10:00
Introducing Sonas Financial Planning: A New Approach to Personalized Financial Guidance
00:10:00
An engaged and experienced Board of Directors can help guide a company to success|David Motley,General Partner,Black Tech Nation Ventures
00:10:00
Warren Gilman on Mining Sector's Performance and Generalist Interest in Gold Miners
00:10:00
Identity Security: The Foundation for a Secure Enterprise|BarakKaufman,Senior Director, Product, SailPoint
00:10:00
Vew funding from so many potential firms|Mary Meeker,General Partner, Bond Capital
00:10:00
Giyani Metals' 2021 Transformational Year and Project Overview
00:10:00
Globe President and CEO Ernest Cu received a prestigious Lifetime Achievement and Contribution award for his contributions to the telecom industry.
00:10:00
Vijay Chandok of ICICI Securities discusses the sustained growth in derivatives income and initiatives to expand the business on ET NOW.
00:10:00
Unpacking Absolute Return Strategies: Neil Capecci on Global Fixed Income and Client-Centered Investing | Neil Capecci - Portfolio Manager, Manulife
00:10:00
Business of Biotech- Trends in Life Science Funding & Exits|Tim Shannon,General Partner,Canaan Partners